Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment

Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment

There are limited reports regarding early predictors of objective response (OR) in patients with hepatocellular carcinoma (HCC) treated with lenvatinib. This retrospective study including 70 patients aimed to investigate the efficacy of hepatic biochemical markers. Changes in tumor marker (alpha-fet...

Full description

Bibliographic Details
Main Authors: Issei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, Tadasuke Hanazono, Yohei Urata, Takakazu Furutani, Yuichiro Yokoyama, Toshiyuki Oishi, Masaki Maeda, Teruaki Kimura, Yurika Kotoh, Ryo Sasaki, Takashi Miyaji, Takashi Oono, Yuki Aibe, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
hepatocellular carcinoma
lenvatinib
molecular targeted agent
objective response
Online Access:https://www.mdpi.com/2072-6694/12/4/779

Internet

https://www.mdpi.com/2072-6694/12/4/779

Similar Items